Elena Lvov, APRN
Family · East Providence, RINPI 1023448925
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.7% of the total across 295 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 25 manufacturers reported payments, led by GSK at 24.6% of the total. Reporting peaked in 2023 at $2,556 and has fallen 94.7% since, to $134 in 2025. Among family clinicians in RI with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 295 payments — averaging $23.73 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- GSK$2K
- AstraZeneca$2K
- Sanofi$1K
- Regeneron Healthcare Solutions, Inc.$755
- Optinose US, Inc.$397
- Pfizer$323
- plus $1K from 19 others
What the payments were for
- Food & beverage$6,977100%
- Education$230%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| GSK | 71 | $1,723 |
| AstraZeneca | 56 | $1,595 |
| Sanofi | 30 | $1,027 |
| Regeneron Healthcare Solutions, Inc. | 28 | $755 |
| Optinose US, Inc. | 29 | $397 |
| Pfizer | 23 | $323 |
| Biohaven Pharmaceutical Holding Company Ltd. | 14 | $193 |
| AbbVie | 6 | $152 |
| Mylan Specialty L.p. | 1 | $122 |
| Kaleo, Inc. | 8 | $121 |
| Paratek Pharmaceuticals, Inc. | 1 | $96 |
| Alk-abello, Inc | 5 | $80 |
| Covis Pharma GmbH | 3 | $57 |
| Teva Pharmaceuticals USA, Inc. | 3 | $52 |
| Pharming Healthcare, Inc. | 2 | $42 |
| CSL Behring | 2 | $34 |
| Boehringer Ingelheim | 2 | $33 |
| Watermark Medical, Inc. | 2 | $33 |
| Stryker | 1 | $32 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $32 |
| Hikma Pharmaceuticals USA | 2 | $31 |
| Aimmune Therapeutics, Inc. | 2 | $28 |
| Amgen | 1 | $17 |
| Novartis | 1 | $15 |
| Eyevance Pharmaceuticals LLC | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$7,000 in reported general payments places this provider in the 95th percentile of 457 family providers in Rhode Island.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Fluticasone Propionate | 180 | $3,608 |
| Ipratropium Bromide | 87 | $3,159 |
| Azelastine Hcl | 61 | $2,166 |
| Mometasone Furoate | 25 | $1,725 |
| Montelukast Sodium | 46 | $609 |
| Levocetirizine Dihydrochloride | 17 | $458 |
Paid to pharmacies, not to this prescriber.
Other family in East Providence
- Danielle BarryEast Providence$4K
- Carol RobinsonWarwick$82K
- Mark ClarkeSmithfield$37K
- Olga FedorenkoCoventry$24K
- Alicia VatterWarwick$15K
- Kaleigh RapozaJohnston$14K
- David RamosRiverside$14K
- Sharon BensonNorth Smithfield$12K
- Michelle Blade MelloWest Warwick$12K
- Shrenik VyasLincoln$11K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.